v3.26.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Common Stock
Series B Common Stock
Common stock
Series A Common Stock
Common stock
Series B Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance at Dec. 31, 2024 $ 155,805     $ 3   $ 450,883 $ (295,311) $ 230
Beginning balance (in shares) at Dec. 31, 2024       30,674,855 1,520,490      
Increase (Decrease) In Stockholders' Deficit                
Stock-based compensation expense 1,472         1,472    
Unrealized loss on marketable securities (109)             (109)
Net loss (18,176)           (18,176)  
Ending balance at Mar. 31, 2025 138,992     $ 3   452,355 (313,487) 121
Ending balance (in shares) at Mar. 31, 2025       30,674,855 1,520,490      
Beginning balance at Dec. 31, 2024 155,805     $ 3   450,883 (295,311) 230
Beginning balance (in shares) at Dec. 31, 2024       30,674,855 1,520,490      
Increase (Decrease) In Stockholders' Deficit                
Unrealized loss on marketable securities (154)              
Net loss (28,562)              
Ending balance at Jun. 30, 2025 130,160     $ 3   453,954 (323,873) 76
Ending balance (in shares) at Jun. 30, 2025       30,674,954 1,520,490      
Beginning balance at Mar. 31, 2025 138,992     $ 3   452,355 (313,487) 121
Beginning balance (in shares) at Mar. 31, 2025       30,674,855 1,520,490      
Increase (Decrease) In Stockholders' Deficit                
Issuance of Series A Common Stock upon exercise of stock options 1         1    
Issuance of Series A Common Stock upon exercise of stock options (in shares)       99        
Stock-based compensation expense 1,598         1,598    
Unrealized loss on marketable securities (45)             (45)
Net loss (10,386)           (10,386)  
Ending balance at Jun. 30, 2025 130,160     $ 3   453,954 (323,873) 76
Ending balance (in shares) at Jun. 30, 2025       30,674,954 1,520,490      
Beginning balance at Dec. 31, 2025 111,381     $ 3   457,607 (346,349) 120
Beginning balance (in shares) at Dec. 31, 2025   31,954,105 567,494 31,954,105 567,494      
Increase (Decrease) In Stockholders' Deficit                
Issuance of Series A Common Stock for vesting of restricted stock units (in shares)       63,508        
Stock-based compensation expense 1,839         1,839    
Unrealized loss on marketable securities (112)             (112)
Net loss (10,650)           (10,650)  
Ending balance at Mar. 31, 2026 102,458     $ 3   459,446 (356,999) 8
Ending balance (in shares) at Mar. 31, 2026       32,017,613 567,494      
Beginning balance at Dec. 31, 2025 111,381     $ 3   457,607 (346,349) 120
Beginning balance (in shares) at Dec. 31, 2025   31,954,105 567,494 31,954,105 567,494      
Increase (Decrease) In Stockholders' Deficit                
Unrealized loss on marketable securities (197)              
Net loss (24,603)              
Ending balance at Jun. 30, 2026 256,155     $ 6   627,178 (370,952) (77)
Ending balance (in shares) at Jun. 30, 2026   61,215,440 567,494 61,215,440 567,494      
Beginning balance at Mar. 31, 2026 102,458     $ 3   459,446 (356,999) 8
Beginning balance (in shares) at Mar. 31, 2026       32,017,613 567,494      
Increase (Decrease) In Stockholders' Deficit                
Sale of Series A common stock, net of issuance costs 163,855     $ 3   163,852    
Sale of Series A common stock, net of issuance costs (in shares)       29,166,700        
Issuance of Series A Common Stock upon exercise of stock options 96         96    
Issuance of Series A Common Stock upon exercise of stock options (in shares)       15,056        
Issuance of Series A common stock for purchases under employee stock purchase plan 93         93    
Issuance of Series A common stock for purchases under employee stock purchase plan (in shares)       16,071        
Stock-based compensation expense 3,691         3,691    
Unrealized loss on marketable securities (85)             (85)
Net loss (13,953)           (13,953)  
Ending balance at Jun. 30, 2026 $ 256,155     $ 6   $ 627,178 $ (370,952) $ (77)
Ending balance (in shares) at Jun. 30, 2026   61,215,440 567,494 61,215,440 567,494